CD10-positive stromal cells in gastric carcinoma: Correlation with invasion and metastasis

Japanese Journal of Clinical Oncology

Volumn 35, Issue 5, 2005, Pages 245-250

  Huang, Wen Bin ^a   Zhou, Xiao Jun ^a   Chen, Jie Yu ^a   Zhang, Li Hua ^a   Meng, Kui ^a   Ma, Heng Hui ^a   Lu, Zhen Feng ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

CD10; Gastric cancer; Immunohistochemistry; Invasion; Metastasis; Stromal cell

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; MONOCLONAL ANTIBODY; MEMBRANE METALLOENDOPEPTIDASE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN SYNTHESIS; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH MUCOSA; STROMA CELL; VASCULAR DISEASE; CARCINOMA; IMMUNOLOGY; LYMPH NODE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEPRILYSIN; STOMACH NEOPLASMS; STROMAL CELLS;

EID: 21744435591     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyi076     Document Type: Article

References (36)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-6.
2. Tuxhorn JA, Ayala GE, Rowley DR. Reactive stroma in prostate cancer progression. J Urol 2001;166:2472-83.
3. Lagace R, Grimaud JA, Schurch W, Seemayer TA. Myofibroblastic stromal reaction in carcinoma of the breast: Variations of collagenous matrix and structural glycoproteins. Virchows Arch A Pathol Anat Histopathol 1985;408:49-59.
4. Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 1999;5:1041-56.
5. Mackie EJ, Chiquet-Ehrismann R, Pearson CA, Inaguma Y, Taya K, Kawarada Y, et al. Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc Natl Acad Sci USA 1987;84:4621-5.
6. Hauptmann S, Zardi L, Siri A, Carnemolla B, Borsi L, Castellucci M, et al. Extracellular matrix proteins in colorectal carcinomas. Expression of tenascin and fibronectin isoforms. Lab Investig 1995;73:172-82.
7. Hanamura N, Yoshida T, Matsumoto E, Kawarada Y, Sakakura T. Expression of fibronectin and tenascin-C mRNA by myofibroblasts, vascular cells, and epithelial cells in human colon adenomas and carcinomas. Int J Cancer 1997;73:10-5.
8. Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ, Rettig WJ. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem 1999;274:36505-12.
9. DeClerck YA. Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer. Eur J Cancer 2000;36:1258-68.
10. Mumford RA, Pierzchala PA, Strauss AW, Zimmerman M. Purification of a membrane-bound metalloendopeptidase from porcine kidney that degrades peptide hormones. Proc Natl Acad Sci USA 1981;78:6623-7.
11. Patey G, Baume SDL, Schwartz JC, Gros C, Roques B, Fournie-Zaluski MC, et al. Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition. Science 1981;212:1153-5.
12. Shipp MA, Vijayaraghavam J, Schmidt EV, Masteller EL, D'Adamio L, Hersh LB, et al. Common acute lymphoblastic leukemia antigen (CALLA) is active neutral endopeptidase 24.11 ('enkephalinase'): Direct evidence by cDNA transfection analysis. Proc Natl Acad Sci USA 1989;86:297-301.
13. Chu PG, Arber DA. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol 2000;113:374-82.
14. McIntosh GG, Lodge AJ, Watson P, Hall AG, Wood K, Anderson JJ, et al. NCL-CD10-270: A new monoclonal antibody recognizing CD10 in paraffin-embedded tissue. Am J Pathol 1999;154:77-82.
15. Greaves MF, Hariri G, Newman RA, Sutherland DR, Ritter MA, Ritz J. Selective expression of the common acute lymphoblastic leukemia (gp100) antigen on immature lymphoid cells and their malignant counterparts. Blood 1983;61:628-39.
16. Moreau I, Duvert V, Caux C, Galmiche MC, Charbord P, Banchereau J, et al. Myofibroblastic stromal cells isolated from human bone marrow induce the proliferation of both early myeloid and B-lymphoid cells. Blood 1993;82:2396-405.
17. Imai K, Kanazaki H, Fujikawa H, Kariya M, Takakura K, Kanzaki H, et al. Expression of aminopeptidase N and neutral endopeptidase on the endometrial stromal cells in endometriosis and adenomyosis. Hum Reprod 1992;7:1326-8.
18. Iwaya K, Ogawa H, Izumi M, Kuroda M, Mukai K. Stromal expression of CD10 in invasive breast carcinoma: A new predictor of clinical outcome. Virchows Arch 2002;440:589-93.
19. Ogawa H, Iwaya K, Izumi M, Kuroda M, Serizawa H, Koyanagi Y, et al. Expression of CD10 by stromal cells during colorectal tumor development. Hum Pathol 2002;33:806-11.
20. Murray MJ, Cunningham JM, Parada LF, Dautry F, Lebowitz P, Weinberg RA. The HL-60 transforming sequence: A ras oncogene coexisting with altered myc genes in hematopoietic tumors. Cell 1983;33:749-57.
21. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
22. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
23. Ronnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast: Importance of the stromal reaction. Physiol Rev 1996;76:69-125.
24. Kinzler KW, Vogelstein B. Landscaping the cancer terrain. Science 1998;280:1036-7.
25. Skobe M, Fusenig NE. Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. Proc Natl Acad Sci USA 1998;95:1050-5.
26. Tran NL, Nagle RB, Cress AE, Heimark RL. N-Cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion with stromal cells. Am J Pathol 1999;155:787-98.
27. Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ, Rettig WJ. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem 1999;274:36505-12.
28. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, et al. The stromal proteinase MMP3/Stromelysin-1 promotes mammary carcinogenesis. Cell 1999;98:137-46.
29. Lieubeau B, Heymann MF, Henry F, Barbieux I, Meflah K, Gregoire M. Immunomodulatory effects of tumor-associated fibroblasts in colorectal-tumor development. Int J Cancer 1999;81:629-36.
30. Dimanche-Boitrel MT, Vakaet L, Pujuguet P, Chauffert B, Martin MS, Hammann A, et al. In vivo and in vitro invasiveness of a rat colon-cancer cell line maintaining E-cadherin expression: An enhancing role of tumor-associated mypfibroblasts. Int J Cancer 1994; 56:512-21.
31. Leiwill MF. Current practical applications of diagnostic immunohistochemistry in breast pathology. Am J Surg Pathol 2004; 28:1076-91.
32. Xiao SY, Wang HL, Hart J, Fleming D, Beard MR. CDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma. Am J Pathol 2001;159:1415-21.
33. Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol 2000;24:203-10.
34. Koiso K, Akaza H, Ohtani M, Miyanaga N, Aoyagi K. A new tumor marker for bladder cancer. Int J Urol 1994;1:33-6.
35. Sato Y, Itoh F, Hinoda Y, Ohe Y, Nakagawa N, Ueda R, et al. Expression of CD10/neutral endopeptidase in normal and malignant tissues of the human stomach and colon. J Gastroenterol 1996;31:12-7.
36. Pan C, Cardarelli PM, Nieder MH, Pickford LB, Gangwar S, King DJ, et al.. CD10 is a key enzyme involved in the activation of tumor-activated peptide prodrug CPI-0004Na and novel analogues: Implications for the design of novel peptide prodrugs for the therapy of CD10+ tumors. Cancer Res 2003;63:5526-31.